Indications and uses
Helps prevent recurrence of flaking and itching associated with dandruff and seborrheic dermatitis.
Helps prevent recurrence of flaking and itching associated with dandruff and seborrheic dermatitis.
1. Wet hair with warm water. Distribute shampoo evenly onto scalp and hair creating a rich lather. Rinse. 2. Reapply for maximum results. Rinse. Apply Therapeutic™ Scalp and Hair Treatment Rinse working onto scalp and through the hair. 3. Thoroughly rinse. Consult your Salon professional for additional Mediceuticals® scalp and hair treatments specifically tailored for your condition.
Salicylic Acid 1.8%
Anti-dandruff, anti-seborrheic dermatitis
Helps prevent recurrence of flaking and itching
associated with dandruff and seborrheic dermatitis.
For external use only. If condition worsens or does not improve after regular use of this product as directed, discontinue and consult a physician. If condition covers a large area of the body, consult your physician before using this product.
If swallowed, get medical help or contact a Poison Control Center right away. Avoid contact with eyes. If contact occurs, rinse eyes thoroughly with cool water.
1. Wet hair with warm water. Distribute shampoo evenly onto scalp
and hair creating a rich lather. Rinse.
2. Reapply for maximum results. Rinse. Apply Therapeutic™ Scalp and
Hair Treatment Rinse working onto scalp and through the hair.
3. Thoroughly rinse.
Consult your Salon professional for additional Mediceuticals® scalp
and hair treatments specifically tailored for your condition.
Aloe Barbadensis Leaf Juice, Apigenin, Biotin, Biotynoyl Tripeptide-1, Butylene
Glycol, Butylphenyl Methyl Propional, Chamomilla Recutita (Matricaria) Flower
Extract, Citric Acid, Citronellol, Cocamide DEA, Cocamidopropyl Betaine, Cucumis
Sativus (Cucumber) Extract, Dimethicone, Fragrance (Parfum), Glycerin, Glycol
Stearate, Helianthus Annuus (Sunflower) Seed Extract, Linalool, Methylchloroisothiazolinone,
Methylisothiazolinone, Oleanic Acid, Panthenol, PEG-40 Hydrogenated
Castor Oil, PEG-150 Distearate, PPG-26-Buteth-26, Simmondsia Chinensis
(Jojoba) Seed Oil, Sodium C14-16 Olefin Sulfonate, Water (Aqua)
MediceuticalXDermaLabel180mL.jpg
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59279-507-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-27a0-f424-e053-dadaa90a57ce | Mediceutical Laboratories X-Derma Dry Scalp and Hair Treatment - Drug Facts |
| 59279-507-12 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-27a0-f424-e053-dadaa90a57ce | Mediceutical Laboratories X-Derma Dry Scalp and Hair Treatment - Drug Facts |
| 59279-507-33 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-27a0-f424-e053-dadaa90a57ce | Mediceutical Laboratories X-Derma Dry Scalp and Hair Treatment - Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59279-507-06 | Mediceuticals X-DermaDry Scalp and Hair Treatment | 180 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 180 | 10 | |
| 59279-507-12 | Mediceuticals X-DermaDry Scalp and Hair Treatment | 360 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 360 | 10 | |
| 59279-507-33 | Mediceuticals X-DermaDry Scalp and Hair Treatment | 1000 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 1000 | 10 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Salicylic Acid | ACTIVE INGREDIENT | O414PZ4LPZ | 7 | |
| Salicylic Acid | ACTIVE MOIETY | O414PZ4LPZ | 7 | |
| .Beta.-Citronellol, (R)- | INACTIVE INGREDIENT | P01OUT964K | 7 | |
| 1-Butene | INACTIVE INGREDIENT | LY001N554L | 7 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 7 | |
| Apigenin | INACTIVE INGREDIENT | 7V515PI7F6 | 7 | |
| Biotin | INACTIVE INGREDIENT | 6SO6U10H04 | 7 | |
| Biotinoyl Tripeptide-1 | INACTIVE INGREDIENT | O6380721VA | 7 | |
| Butylphenyl Methylpropional | INACTIVE INGREDIENT | T7540GJV69 | 7 | |
| Chamomile | INACTIVE INGREDIENT | FGL3685T2X | 7 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 7 | |
| Cocamidopropyl Betaine | INACTIVE INGREDIENT | 5OCF3O11KX | 7 | |
| Coco Diethanolamide | INACTIVE INGREDIENT | 92005F972D | 7 | |
| Cucumber Seed | INACTIVE INGREDIENT | BT3S9L53JK | 7 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 7 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 7 | |
| LINALOOL, ()- | INACTIVE INGREDIENT | D81QY6I88E | 7 | |
| Methylchloroisothiazolinone | INACTIVE INGREDIENT | DEL7T5QRPN | 7 | |
| Methylisothiazolinone | INACTIVE INGREDIENT | 229D0E1QFA | 7 | |
| Panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 7 | |
| PEG-150 Distearate | INACTIVE INGREDIENT | 6F36Q0I0AC | 7 | |
| Polyoxyl 40 Hydrogenated Castor Oil | INACTIVE INGREDIENT | 7YC686GQ8F | 7 | |
| Simmondsia Chinensis Seed Wax | INACTIVE INGREDIENT | 47X6Y9FJJ2 | 7 | |
| Sodium C14-16 Olefin Sulfonate | INACTIVE INGREDIENT | O9W3D3YF5U | 7 | |
| Sunflower Seed | INACTIVE INGREDIENT | R9N3379M4Z | 7 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 7 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59279-507 | 59279-507-06, 59279-507-12, 59279-507-33 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRACARDIAC | 1.05 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 608 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / ORAL | 446 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Polyoxyl 40 Hydrogenated Castor Oil | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | SOLUTION / OPHTHALMIC | 3 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| Coco Diethanolamide | COCO DIETHANOLAMIDE | 92005F972D | SOLUTION / TOPICAL | 2.5 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| Polyoxyl 40 Hydrogenated Castor Oil | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | SOLUTION / ORAL | 3240 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRASYNOVIAL | ADJ PH | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| Polyoxyl 40 Hydrogenated Castor Oil | POLYOXYL 40 HYDROGENATED CASTOR OIL | 7YC686GQ8F | CAPSULE / ORAL | 3319 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 28021efc-b567-404f-e054-00144ff88e88 | ad02bbdf-2680-4d03-bcf1-1ba74928373e | 2015-12-28 | Warnings | 28021efc-b567-404f-e054-00144ff88e88 ad02bbdf-2680-4d03-bcf1-1ba74928373e |
Adverse event summaries are temporarily unavailable. Other product information remains available.